A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Saccharomyces cerevisiae (baker's yeast) is the paradigm eukaryotic fermentation organism, converting glucose to ethanol and CO₂ with high efficiency. Yeasts exhibit the Crabtree effect (glucose repression of respiration even with available oxygen), favoring fermentation over respiration. Beyond beverages, yeasts are engineered for recombinant protein production, synthetic biosynthetic pathways, and biofuel generation, making them cornerstones of modern biotechnology.
You already understand that fermentation is an anaerobic pathway that regenerates NAD⁺ by reducing pyruvate to various end products, and that different microorganisms produce different fermentation products. Saccharomyces cerevisiae — common baker's and brewer's yeast — performs alcoholic fermentation, converting pyruvate first to acetaldehyde (releasing CO₂) and then to ethanol (oxidizing NADH back to NAD⁺). This two-step pathway is what makes bread rise (the CO₂ creates gas bubbles in dough) and what produces alcohol in beer, wine, and spirits (the ethanol accumulates in the liquid).
What makes yeast metabolism particularly interesting is the Crabtree effect: when glucose is abundant, *S. cerevisiae* ferments even in the presence of oxygen. Most organisms you have studied switch to aerobic respiration when oxygen is available because it yields far more ATP per glucose molecule — about 30-32 ATP via oxidative phosphorylation versus just 2 ATP from fermentation. Yeast breaks this rule. At high glucose concentrations, yeast represses the genes for mitochondrial respiration and channels pyruvate toward ethanol production regardless of oxygen availability. The evolutionary logic is a competition strategy: by fermenting rapidly, yeast produces ethanol that is toxic to competing microorganisms, effectively poisoning its neighbors while tolerating the alcohol itself (up to about 15% concentration). Speed of resource consumption matters more than efficiency of energy extraction when you are competing for a sugar-rich niche like ripe fruit.
This metabolic flexibility has made yeast indispensable in biotechnology far beyond traditional brewing and baking. As a eukaryote, *S. cerevisiae* can perform protein folding and post-translational modifications (like glycosylation) that bacteria cannot, making it a preferred host for producing recombinant proteins such as insulin and hepatitis B vaccine antigens. Its well-characterized genetics — yeast was the first eukaryote to have its genome fully sequenced — and ease of genetic manipulation have made it a platform organism for synthetic biology. Researchers engineer yeast with entirely new biosynthetic pathways to produce compounds the organism would never naturally make: artemisinic acid (a precursor to the antimalarial drug artemisinin), opioid precursors, and even synthetic fragrances.
Yeast is also central to biofuel production. Engineering strains to ferment not just glucose but also the five-carbon sugars (like xylose) found in lignocellulosic biomass — agricultural waste, wood chips, and switchgrass — is a major research frontier. Wild-type *S. cerevisiae* cannot efficiently metabolize xylose, so metabolic engineers have introduced xylose isomerase pathways and optimized pentose phosphate flux to expand the substrate range. The goal is to convert cheap, abundant plant waste into ethanol at industrial scale, reducing dependence on food crops as fermentation feedstock. Understanding yeast metabolism at the pathway level is what makes these engineering efforts possible: every intervention requires knowing which enzymes to add, which to knock out, and how metabolic flux will redistribute in response.